Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating APP13007 for safety, tolerability, and preliminary efficacy in ocular inflammation and pain after cataract surgery has completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation After Cataract Surgery
• Postoperative Ocular Pain

Drugs mentioned

• APP13007

Snippet

Sponsor: Formosa Pharmaceuticals, Inc. | Conditions: Ocular Inflammation and Pain After Cataract Surgery | Phase 2 | Status: COMPLETED | Results posted: 2023-06-27